Skip to search formSkip to main contentSkip to account menu

AVE 0991

Known as: AVE0991 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background Neonatal therapy with a high concentration of oxygen (hyperoxia) is a known cause of bronchopulmonary dysplasia (BPD… 
2016
2016
This study investigated the acute effects of angiotensin-(1-7) and AVE0991 on active tone and vasodilator responses to bradykinin… 
2013
2013
The detrimental role of over activation of renin-angiotensin system (RAS) in atherogenesis is widely recognized. Recently, we… 
2012
2012
Hypothesis: This study was designed to investigate the cardio-renal protective effect of AVE-0991, a non-peptide Mas-receptor… 
2012
2012
Objectives To observe the effects of nonpeptide angiotensin-(1–7) (Ang-(1–7)) analogue AVE0991 on Matrix Metalloproteinase-2 (MMP… 
2010
2010
The nonpeptide AVE0991 is expected to be a putative new drug for cardiovascular diseases. However, the mechanisms for the… 
2007
2007
We evaluated the effect of the nonpeptide mimic of angiotensin (Ang)-(1-7), AVE 0991, on the hypotensive effect of bradykinin (BK…